Cargando…

Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments

This review considers whether a case can be made for a protective effect of inhibitors and blockers of the renin–angiotensin–aldosterone system (RAAS) on the cerebral circulation. It first looks at whether there exists a preferential effect on the cerebral circulation during a drug-induced lowering...

Descripción completa

Detalles Bibliográficos
Autor principal: Atkinson, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108479/
https://www.ncbi.nlm.nih.gov/pubmed/21687514
http://dx.doi.org/10.3389/fphar.2011.00022
_version_ 1782205316588371968
author Atkinson, Jeffrey
author_facet Atkinson, Jeffrey
author_sort Atkinson, Jeffrey
collection PubMed
description This review considers whether a case can be made for a protective effect of inhibitors and blockers of the renin–angiotensin–aldosterone system (RAAS) on the cerebral circulation. It first looks at whether there exists a preferential effect on the cerebral circulation during a drug-induced lowering of high arterial blood pressure and cardiovascular morbi-mortality. It then goes on to consider background studies on the relationship between inhibition of the RAAS and stroke. This is followed by exploration of possible new directions in the inhibition of the RAAS and its effect on stroke.
format Online
Article
Text
id pubmed-3108479
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-31084792011-06-16 Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments Atkinson, Jeffrey Front Pharmacol Pharmacology This review considers whether a case can be made for a protective effect of inhibitors and blockers of the renin–angiotensin–aldosterone system (RAAS) on the cerebral circulation. It first looks at whether there exists a preferential effect on the cerebral circulation during a drug-induced lowering of high arterial blood pressure and cardiovascular morbi-mortality. It then goes on to consider background studies on the relationship between inhibition of the RAAS and stroke. This is followed by exploration of possible new directions in the inhibition of the RAAS and its effect on stroke. Frontiers Research Foundation 2011-04-27 /pmc/articles/PMC3108479/ /pubmed/21687514 http://dx.doi.org/10.3389/fphar.2011.00022 Text en Copyright © 2011 Atkinson. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
spellingShingle Pharmacology
Atkinson, Jeffrey
Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
title Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
title_full Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
title_fullStr Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
title_full_unstemmed Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
title_short Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
title_sort stroke, high blood pressure and the renin–angiotensin–aldosterone system – new developments
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108479/
https://www.ncbi.nlm.nih.gov/pubmed/21687514
http://dx.doi.org/10.3389/fphar.2011.00022
work_keys_str_mv AT atkinsonjeffrey strokehighbloodpressureandthereninangiotensinaldosteronesystemnewdevelopments